BRITTANY BAILEY: Open Payments
NPI 1952188815 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,002 in 45 payments from 13 companies in 2025. Trend: 2023 $53 · 2024 $1,635 · 2025 $1,002
Food & beverage: $1,002
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 13 | $270 |
| Lundbeck LLC | 7 | $193 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $130 |
| ABBVIE INC. | 5 | $89 |
| Corium, LLC | 3 | $73 |
| Neurocrine BioSciences, Inc. | 2 | $67 |
| Janssen Pharmaceuticals, Inc | 2 | $42 |
| Supernus Pharmaceuticals, Inc. | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| Bausch Health US, LLC | 1 | $23 |
Products named: REXULTI, CAPLYTA, VRAYLAR, Azstarys, INGREZZA, SPRAVATO, Qelbree, COBENFY.
Industry payments across VA — which companies pay providers there.
